Scholars Central

Conference abstractPublished 5 Feb 2020

Ethnobotanical and ethnotherapeutic investigations on plant species used in the treatment of T2D in Guinean traditional medicine

Authors: F Bah, E S Balde, M S Traore, A O Balde, N M Balde, T O Keita, D Dioubate, A Camara, A D Doumbouya, A L Minthe, M A Diallo, F M Camara, L Diallo, A M Balde

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

As in other sub-Saharan Africa countries, the majority of Guinean population depend on traditional and herbal medicines, for their healthcare needs. Although traditional medicine knowledge have been passed on orally among traditional health practioners for many generations, concern has been often raised about the effectiveness and security of their remedies. Aiming to improve the health conditions of the populations through a rational use of the Guinean Pharmacopea and Traditional Medicine, an ethnobotanical Investigation, an ethnobotanical Investigation conducted in the middle and coastal lowlands of Guinea made it possible to contact 198 traditional healers, 108 herbalists and 397 diabetic patients. An inventory of 188 identified plant species belonging to 55 botanical families was made. Based on their quotation over healers, herbalists and consumers, based also on their distribution, longtime use, 8 plant species were selected viz Englerina lecardii, Combretum glutinosum, Ficus glumosa, Jatropha gossypifolia, Anacardium occidentale, Hymenocardia acida, Bauhinia thonningii, Spathodea campanulata. When subjected to ethnotherapeutic evaluation on volunteer patients for a period of 2 to 6 months, slight, modest and significant declines in fasting blood sugar were recorded, depending on the species. The lowest blood sugar (2.14 from the baseline to 1.15 g/L at the end of treatment) were recorded with patients treated with he extract of « Sattagas ». Upon consideration of these results, Guinean medicinal plant species may constitute a source of new bioactive molecules for the management of type2 diabetes.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Endocrine Disorders & Surgery.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Endocrine Disorders & Surgery
  • SubjectDiabetes & Endocrinology
  • SubjectSurgery
  • BylineArticles whose byline prints “F Bah”
  • BylineArticles whose byline prints “E S Balde”
  • BylineArticles whose byline prints “M S Traore”
  • BylineArticles whose byline prints “A O Balde”
  • BylineArticles whose byline prints “N M Balde”
  • BylineArticles whose byline prints “T O Keita”
  • BylineArticles whose byline prints “D Dioubate”
  • BylineArticles whose byline prints “A Camara”